.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Fish and Richardson
Healthtrust
McKinsey
Cipla
Novartis
QuintilesIMS
Medtronic
Chinese Patent Office
Express Scripts

Generated: July 20, 2017

DrugPatentWatch Database Preview

Tetrahydrozoline hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for tetrahydrozoline hydrochloride and what is the scope of tetrahydrozoline hydrochloride freedom to operate?

Tetrahydrozoline hydrochloride
is the generic ingredient in one branded drug marketed by Fougera Pharms and is included in one NDA. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are two drug master file entries for tetrahydrozoline hydrochloride.

Summary for Generic Name: tetrahydrozoline hydrochloride

Tradenames:1
Patents:1
Applicants:1
NDAs:1
Drug Master File Entries: see list2
Bulk Api Vendors: see list51
Clinical Trials: see list2,245
Patent Applications: see list1,552
Therapeutic Class:Respiratory Tract Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:tetrahydrozoline hydrochloride at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fougera Pharms
TYZINE
tetrahydrozoline hydrochloride
SOLUTION;NASAL086576-002Approved Prior to Jan 1, 1982RXNoYes► Subscribe► Subscribe
Fougera Pharms
TYZINE
tetrahydrozoline hydrochloride
SPRAY;NASAL086576-003Approved Prior to Jan 1, 1982RXNoYes► Subscribe► Subscribe
Fougera Pharms
TYZINE
tetrahydrozoline hydrochloride
SOLUTION;NASAL086576-001Approved Prior to Jan 1, 1982RXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
UBS
Argus Health
Federal Trade Commission
Chinese Patent Office
Citi
Fish and Richardson
Boehringer Ingelheim
Healthtrust
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot